Skip to main content
Premium Trial:

Request an Annual Quote

Mesa Biotech Point-of-Care Testing Platform Garners CE Mark

NEW YORK (GenomeWeb) — Mesa Biotech said today that its PCR testing platform for point-of-care infectious disease testing has obtained CE marking in the EU.

The first available test in the EU market will be the company's Flu A/Flu B test.

The Accula System is a palm-sized device that accepts disposable test cassettes. The cassette contains all necessary reagents for lysis and nucleic acid amplification. The system does not require as much power as a standard thermal cycler, and can be run using a rechargeable battery pack. Readout is performed on a lateral flow strip, with results available in about 30 minutes.

"The introduction of the Accula System and its Flu A/Flu B test as our first PCR assay in the European market is an important validation of our platform and a critical strategic milestone for Mesa Biotech," Mesa CEO and Founder Hong Cai said in a statement. "Our proprietary assay design enables rapid development of a portfolio of cassettes to test for human, agricultural, food pathogens, or genetic disease targets."

In December, Mesa announced a distribution deal with Sekisui Diagnostics, which will exclusively distribute the Accula system and flu test in the US and Canada pending regulatory clearance in those countries.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.